Related Experiment Video

Updated: May 27, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells

Anja Rabien1, Hugo Sanchez-Ruderisch, Petra Schulz

  • 1Division of Gastroenterology, Department of Internal Medicine, Charité- Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany. anja.rabien@charite.de

Cancer Science
|November 5, 2011
PubMed

Insights

Restoring the cell cycle inhibitor p16(INK4a) in pancreatic cancer suppresses oncogenic K-Ras activity. This interaction is crucial for reversing cancer cell transformation and anoikis resistance, offering new therapeutic insights.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic cancer frequently exhibits activated K-Ras and inactivated p16(INK4a).
  • Previous work showed p16(INK4a) reintroduction reverses anoikis resistance and clonogenicity in pancreatic cancer cells.
  • The role of K-Ras following p16(INK4a) re-expression remained to be elucidated.

Purpose of the Study:

  • To investigate the functional interaction between K-Ras and p16(INK4a) in pancreatic cancer.
  • To determine the effect of p16(INK4a) re-expression on K-Ras activity and stability.
  • To understand how K-Ras suppression by p16(INK4a) influences the transformed phenotype.

Main Methods:

  • Reintroduction of p16(INK4a) into pancreatic cancer cell lines (Capan-1, DanG).
  • Assessment of K-Ras activity and protein stability.
  • Analysis of anoikis sensitivity and colony formation assays.
  • Inducible expression systems to control p16(INK4a) levels.

Main Results:

  • Restitution of p16(INK4a) profoundly suppressed K-Ras activity in pancreatic cancer cells.
  • p16(INK4a) re-expression led to reduced K-Ras protein stability.
  • Re-expression of K-Ras reversed the anoikis-sensitive phenotype induced by p16(INK4a).
  • p16(INK4a) expression inhibited K-Ras activity and increased anoikis susceptibility.

Conclusions:

  • p16(INK4a) re-expression suppresses K-Ras activity and stability, reversing the transformed phenotype.
  • This study reveals a novel functional interaction between p16(INK4a) and K-Ras in pancreatic cancer.
  • Targeting this interaction may offer new therapeutic strategies for pancreatic cancer.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...